# Documents

Strategic Architecture Document (SAD) version history for the VDAC1 Gate-Opening Therapeutic Stack.

## Current Version

| Version | File | Format | Date | Pages |
|---------|------|--------|------|-------|
| **v4.0** | `SAD_v4_VDAC1_Gate_Opening_Stack.pdf` | PDF | Feb 2026 | 22 |

## Version History

| Version | Key Changes | Status |
|---------|------------|--------|
| **v4.0** | Complete bench protocol (Sec 3.2) with reagent list and $3,010 budget. TNBC added to Table 1 (4 cancer types). Table 3 restructured around mechanistic evidence chain. Full abbreviations glossary. Publication-ready formatting with TOC, running headers, embedded figures. | **Current** |
| v3.0 | Expanded from 4 to 6 experiments. Complete reagent and cell line specs in Table 2. Added Chou-Talalay CI analysis (Exp 5). Q2-Q4 2026 operational roadmap. Validated support mechanisms table. | Archived |
| v2.0 | Added TSPO cautions (binding ambiguity, overexpression paradox, PK11195 selectivity). Expanded experiment and reference tables. Multi-model synthesis (Claude Opus + Gemini + Grok + Sonnet). | Archived |
| v1.0 | Original 4-experiment architecture. GJS cofactor equation. Three-lock model. Lovastatin as primary gate opener. CBD quarantine established. Botensilimab cavalry concept. | Archived |

## Archive

Older versions preserved in `archive/` with both `.docx` and `.md` formats:

```
archive/
  SAD_v3_VDAC1_Gate_Opening_Stack.docx
  SAD_v3_VDAC1_Gate_Opening_Stack.md
  SAD_v2_VDAC1_Gate_Opening_Stack.docx
  SAD_v2_VDAC1_Gate_Opening_Stack.md
  SAD_v1_VDAC1_Gate_Opening_Stack.docx
  SAD_v1_VDAC1_Gate_Opening_Stack.md
```

## Document Evolution

```
v1.0 (4 experiments, 3-lock model)
  │  Gemini 2.5 Pro synthesis
  ▼
v2.0 (TSPO cautions, expanded tables)
  │  Multi-model review: Claude Opus + Grok + Sonnet
  ▼
v3.0 (6 experiments, reagent specs, timeline)
  │  Chou-Talalay CI addition, operational roadmap
  ▼
v4.0 (bench protocol, TNBC, publication-ready)
     Complete Exp 2a/2b protocol with catalog numbers
     4-lock model formally includes TSPO term
     Table 3: mechanistic evidence chain
```
